Audun Tornes
Chief Tech/Sci/R&D Officer at ULTIMOVACS ASA
Net worth: 55 151 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hans Vassgård Eid | M | 57 | - | |
| Anne Hovi Worsøe | F | 60 | 3 years | |
| Gudrun Trøite | M | - | - | |
| Carlos de Sousa | M | 66 | 4 years | |
| Olav Steinnes | M | 67 |
Inven2 AS
 Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 years |
| Antonius Berkien | M | 56 | 4 years | |
| Ingunn Hagen Westgaard | F | - | - | |
| Haakon Stenrod | M | 44 | 4 years | |
| Jens Bjørheim | M | - | - | |
| Øivind Foss | M | - | - | |
| Kari Grønås | F | 59 | 5 years | |
| Gustav Gaudernack | M | - | - | |
| Ole Kristian Hjelstuen | M | - |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 12 years |
| Henrik Schüssler | M | 61 | 9 years | |
| Ole Kristian Skaar | M | - |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 years |
| Jónas Einarsson | M | 67 | 13 years | |
| Mc Callion Orla | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jostein Christian Dalland | M | 55 |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 18 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Audun Tornes
- Personal Network
